期刊文献+

38例氟喹诺酮药物不良反应分析 被引量:2

Analysis on 38 cases of fluoroquinolones adverse drug reaction report
下载PDF
导出
摘要 目的通过分析氟喹诺酮类药物不良反应,促进临床合理用药。方法对我院2006~2O07年共报告38例氟喹诺酮类药物不良反应,按照患者病情情况、药品种类、给药途径、不艮反应的表现、转归等进行统计分析。结果在年龄分布上无特异性差异,以静脉炎表现(47.37%)、胃肠道反应(31.57%)、中枢神经系统反应(10.52%)为主。引起不良反应的主要药物种类有环丙沙星、左氧氟沙星、诺氟沙星。静脉给药途径引起的不良反应高于口服给药途径。结论合理使用氟喹诺酮类药物,重视药物不良反应的报告和监测,可减少或避免不良反应的重复发生。 Objective To investigate the occurrence of fluoroquinolones antibiotics adverse drug reactions(ADR) and to promote cases collected in our hospital in 2006 to 2007 rational drug use in the clinic. Method 38 were analyzed retrospectively, fluoroquinolones adverse drug reactions, in accordance with the patient's condition, drug type, route of administration, the performance of adverse reactions, such as vesting for statistical analysis. Results The age distribution of non-specific. The mainly manifested adverse drug reaction were phlebitis (47.37%), gastrointestinal reactions (31.57%),and lcentral nervous system reaction (10.52%).Main adverse drug reaction types of ciprofloxacin, levofloxacin, norfloxacin. Intravenous route of administration arising from the adverse effects than oral route of administration. Conclusion The rational use of medication, Importance should be attached to the reporting and monitor of ADR, so as to lessen or avoid the occurrence of ADR in the clinic.
作者 巫小菊
机构地区 增城市新塘医院
出处 《国际医药卫生导报》 2008年第24期63-64,共2页 International Medicine and Health Guidance News
关键词 氟喹诺酮类 不良反应 分析 Fluoroquinolones antibiotics Adverse drug reaction Analysis
  • 相关文献

参考文献8

  • 1金有豫.药理学[M].5版.北京:人民卫生出版社,2001:269—270.
  • 2孙忠实.第5个氟喹诺酮类药品──加替沙星撤市的思考[J].中国药物警戒,2006,3(4):220-222. 被引量:44
  • 3陈新谦,金有豫.新编药物学[M].14版.北京:人民卫生出版社,1999:98-102
  • 4Kahn JB. Latest industry information on the safety profile of levofloxacin in the US[J].Chemotherapy, 2001,47(3):32-42
  • 5Potitjeans F, Nadaud J, Percz JP, et al.h case of rhabdornyolysis with fathal outcome after a treatment with levofloxacin[J].Eun J Clin Phac macol, 2003,59(10): 779-780
  • 6Prothingham R. Rates of torsades de pointes associated with ciprofloxacin, ofloxacin, levofloxacin, gatifloxacin and moxifloxacin[J]. Pharmacother, 2001, 21 (12) : 1468-1472
  • 7Qyigley CA, Lederman JR. Possible gat if loxacin-induced [J]. Ann Pharmacother, 2004, 38 (2) : 235-236
  • 8陈新谦,金有豫,汤光.新编药物学[M].15版.北京:人民卫生出版社,2003:167-171.

二级参考文献5

共引文献129

同被引文献7

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部